GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Mainz Biomed NV (NAS:MYNZ) » Definitions » Other Gross PPE

MYNZ (Mainz Biomed NV) Other Gross PPE : $1.61 Mil (As of Jun. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Mainz Biomed NV Other Gross PPE?

Mainz Biomed NV's Other Gross PPE for the quarter that ended in Jun. 2024 was $1.61 Mil.

Mainz Biomed NV's quarterly Other Gross PPE declined from Sep. 2023 ($2.19 Mil) to Dec. 2023 ($1.59 Mil) but then increased from Dec. 2023 ($1.59 Mil) to Jun. 2024 ($1.61 Mil).

Mainz Biomed NV's annual Other Gross PPE increased from Dec. 2021 ($0.10 Mil) to Dec. 2022 ($0.94 Mil) and increased from Dec. 2022 ($0.94 Mil) to Dec. 2023 ($1.59 Mil).


Mainz Biomed NV Other Gross PPE Historical Data

The historical data trend for Mainz Biomed NV's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mainz Biomed NV Other Gross PPE Chart

Mainz Biomed NV Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Other Gross PPE
0.05 0.08 0.10 0.94 1.59

Mainz Biomed NV Quarterly Data
Dec19 Jun20 Dec20 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Jun24
Other Gross PPE Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.97 2.13 2.19 1.59 1.61

Mainz Biomed NV Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.


Mainz Biomed NV Business Description

Traded in Other Exchanges
N/A
Address
Robert Koch Strasse 5, Sirius Gutenberg Park, Mainz, RP, DEU, 55129
Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples.